NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

CorEvitas Japan Rheumatoid Arthritis (RA) Registry

Active Not RecruitingN/A

Sponsor: CorEvitas

Conditions: Rheumatoid Arthritis

The primary objective is to prospectively study the comparative effectiveness and comparative safety of approved therapies for RA in a Japanese cohort of patients treated by rheumatologists. This includes assessing the incidence of adverse events of special interest, in a real-world population of rheumatoid arthritis patients. Secondary objectives include analyzing the epidemiology and natural history of the disease, comorbidities, and current treatment practices.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* The subject must be diagnosed with rheumatoid arthritis according to the 1987 ACR or the ACR/EULAR 2010 Rheumatoid Arthritis Classification Criteria
* The subject must be at least 18 years of age or older
* The subject must be able and willing to provide written consent
* The subject must be prescribed or switching to an eligible medication for the first time ever at the Enrollment Visit. History of concomitant treatment with other eligible medications does not exclude a subject from enrollment.

Exclusion Criteria:

* The subject is unable or unwilling to provide informed consent to participate in the registry.